Literature DB >> 23419367

Disseminated infection by Mycobacterium sherrisii and Histoplasma capsulatum in an African HIV-infected patient.

Juan Taján1, Mateu Espasa, Montserrat Sala, Marta Navarro, Bernat Font, Julián González-Martín, Ferran Segura.   

Abstract

Mycobacterium sherrisii is a new species of opportunistic, slow-growing, non-tuberculous Mycobacterium closely related to Mycobacterium simiae that can currently be identified with the sequence of 16S rARN gene and the heat-shock protein 65. Few cases of patients infected by this Mycobacterium have been reported and all of them were associated with human immunodeficiency virus or other immunosuppressive conditions. Clinical management is complex, because there is not a clear correlation between the in vitro antibiotic susceptibility testing and the patient's clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419367      PMCID: PMC3752757          DOI: 10.4269/ajtmh.12-0572

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Mycobacterium sherrisii isolation from a patient with pulmonary disease.

Authors:  Enrico Tortoli; Alessandro Mariottini; Gianna Mazzarelli
Journal:  Diagn Microbiol Infect Dis       Date:  2006-08-23       Impact factor: 2.803

2.  Mycobacterium sherrisii: a new opportunistic agent in HIV infection?

Authors:  Pierre Loulergue; Franck Lamontagne; Véronique Vincent; Anne Rossier; Gilles Pialoux
Journal:  AIDS       Date:  2007-04-23       Impact factor: 4.177

3.  [Disease due to Mycobacterium simiae and "Mycobacterium sherrisii" in Argentina].

Authors:  Lucía Barrera; Domingo Palmero; Roxana Paul; Beatriz López
Journal:  Medicina (B Aires)       Date:  2010       Impact factor: 0.653

4.  Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient.

Authors:  Andrea Gämperli; Philipp P Bosshard; Thomas Sigrist; Otto Brändli; Simon Wildermuth; Rainer Weber; Nicolas J Mueller
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.

Authors:  Jakko van Ingen; Sarah E Totten; Niels K Helstrom; Leonid B Heifets; Martin J Boeree; Charles L Daley
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

6.  Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease.

Authors:  Jakko van Ingen; Sarah E Totten; Leonid B Heifets; Martin J Boeree; Charles L Daley
Journal:  Int J Antimicrob Agents       Date:  2011-11-17       Impact factor: 5.283

7.  Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species.

Authors:  Jakko van Ingen; Enrico Tortoli; Rangaraj Selvarangan; Marie B Coyle; John A Crump; Anne B Morrissey; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal:  Int J Syst Evol Microbiol       Date:  2010-07-16       Impact factor: 2.747

8.  Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.

Authors:  G Valero; F Moreno; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov.

Authors:  Rangaraj Selvarangan; Whei-Kuo Wu; Trang T Nguyen; La Donna C Carlson; Carolyn K Wallis; Susan K Stiglich; Yi-Ching Chen; Kenneth C Jost; Jennifer L Prentice; Richard J Wallace; Sara L Rassoulian Barrett; Brad T Cookson; Marie B Coyle
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Invasive disease caused by nontuberculous mycobacteria, Tanzania.

Authors:  John A Crump; Jakko van Ingen; Anne B Morrissey; Martin J Boeree; Daudi R Mavura; Britta Swai; Nathan M Thielman; John A Bartlett; Henning Grossman; Venance P Maro; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more
  3 in total

Review 1.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Rare Mycobacteria and HIV in Children: Two Case Reports.

Authors:  Sarah M Johnson; Cecilia Piñera; Elizabeth Whittaker; Natalie Kirkhope; Onn M Kon; Giovanni Satta; Maria Elvira Balcells; Caroline Foster
Journal:  Clin Drug Investig       Date:  2022-05-16       Impact factor: 3.580

3.  Mycobacterium sherrisii Lung Infection in a Brazilian Patient with Silicosis and a History of Pulmonary Tuberculosis.

Authors:  Carolina de Oliveira Abrão; João Alves de Araújo Filho
Journal:  Case Rep Infect Dis       Date:  2015-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.